胸部计算机断层扫描结果不影响肺病学家对肺部长冠状病毒病的诊断和治疗的决定:一项单中心回顾性研究

IF 1.9 3区 医学 Q3 RESPIRATORY SYSTEM
Journal of thoracic disease Pub Date : 2025-08-31 Epub Date: 2025-08-28 DOI:10.21037/jtd-2025-433
Stefanie Meiler, Daniel Schmalenberger, Maximilian Malfertheiner, Iris Dvorak, Quirin Strotzer, Christian Stroszczynski, Okka Wilkea Hamer
{"title":"胸部计算机断层扫描结果不影响肺病学家对肺部长冠状病毒病的诊断和治疗的决定:一项单中心回顾性研究","authors":"Stefanie Meiler, Daniel Schmalenberger, Maximilian Malfertheiner, Iris Dvorak, Quirin Strotzer, Christian Stroszczynski, Okka Wilkea Hamer","doi":"10.21037/jtd-2025-433","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Pulmonary symptoms are common in long coronavirus disease (COVID), yet the diagnostic value of chest computed tomography (CT) in these patients remains unclear, particularly when physical examination and pulmonary function tests are normal. This study investigates whether chest CT influences the decision of pneumologists regarding the measures taken for diagnostic work-up, the final diagnosis, the confidence in the diagnosis, and the downstream management of patients suspected to suffer from pulmonary long COVID.</p><p><strong>Methods: </strong>All patients presented in a dedicated long COVID outpatient clinic of a secondary care hospital that specializes in lung diseases between April 2020 and August 2021. Inclusion criteria were age ≥18 years, suspicion for long COVID syndrome of pulmonary origin according to the National Institute for Health and Care Excellence (NICE) criteria and availability of a chest CT acquired during work-up. Three pneumologists evaluated the patient's records in two rounds (round 1 without and round 2 with knowledge of CT results). Identical parameters were queried in the two runs: diagnosis of pulmonary long COVID, confidence of the diagnosis on a scale from 0 to 3, need for: bronchoalveolar lavage (BAL), transbronchial biopsy (TBB), cryobiopsy, video-assisted thoracoscopy (VATS), ergospirometry, ventilation/perfusion scintigraphy, follow-up appointment, rehabilitation.</p><p><strong>Results: </strong>Forty-one patients were included (24 male; age 21 to 72 years, mean 55 years). In the first and second round diagnosis of pulmonary long COVID was made in an average of 10 (24%) and 11 (27%) patients (P=0.69). Confidence of diagnosis was 1.9 and 2.6 (P<0.001). No statistical difference was found regarding the frequency of diagnostic measures and downstream management.</p><p><strong>Conclusions: </strong>Chest CT did not influence the diagnostic decision of pneumologists for patients suspected to suffer from pulmonary long COVID. However, the confidence in the diagnosis was improved by chest CT. Still, based on our results chest CT does not routinely have to be included in the work-up of long COVID, when pulmonary function tests and auscultation are normal.</p>","PeriodicalId":17542,"journal":{"name":"Journal of thoracic disease","volume":"17 8","pages":"5654-5662"},"PeriodicalIF":1.9000,"publicationDate":"2025-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12433019/pdf/","citationCount":"0","resultStr":"{\"title\":\"Chest computed tomography findings do not influence the decision of pneumologists regarding the diagnosis and management of pulmonary long coronavirus disease: a single center retrospective study.\",\"authors\":\"Stefanie Meiler, Daniel Schmalenberger, Maximilian Malfertheiner, Iris Dvorak, Quirin Strotzer, Christian Stroszczynski, Okka Wilkea Hamer\",\"doi\":\"10.21037/jtd-2025-433\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Pulmonary symptoms are common in long coronavirus disease (COVID), yet the diagnostic value of chest computed tomography (CT) in these patients remains unclear, particularly when physical examination and pulmonary function tests are normal. This study investigates whether chest CT influences the decision of pneumologists regarding the measures taken for diagnostic work-up, the final diagnosis, the confidence in the diagnosis, and the downstream management of patients suspected to suffer from pulmonary long COVID.</p><p><strong>Methods: </strong>All patients presented in a dedicated long COVID outpatient clinic of a secondary care hospital that specializes in lung diseases between April 2020 and August 2021. Inclusion criteria were age ≥18 years, suspicion for long COVID syndrome of pulmonary origin according to the National Institute for Health and Care Excellence (NICE) criteria and availability of a chest CT acquired during work-up. Three pneumologists evaluated the patient's records in two rounds (round 1 without and round 2 with knowledge of CT results). Identical parameters were queried in the two runs: diagnosis of pulmonary long COVID, confidence of the diagnosis on a scale from 0 to 3, need for: bronchoalveolar lavage (BAL), transbronchial biopsy (TBB), cryobiopsy, video-assisted thoracoscopy (VATS), ergospirometry, ventilation/perfusion scintigraphy, follow-up appointment, rehabilitation.</p><p><strong>Results: </strong>Forty-one patients were included (24 male; age 21 to 72 years, mean 55 years). In the first and second round diagnosis of pulmonary long COVID was made in an average of 10 (24%) and 11 (27%) patients (P=0.69). Confidence of diagnosis was 1.9 and 2.6 (P<0.001). No statistical difference was found regarding the frequency of diagnostic measures and downstream management.</p><p><strong>Conclusions: </strong>Chest CT did not influence the diagnostic decision of pneumologists for patients suspected to suffer from pulmonary long COVID. However, the confidence in the diagnosis was improved by chest CT. Still, based on our results chest CT does not routinely have to be included in the work-up of long COVID, when pulmonary function tests and auscultation are normal.</p>\",\"PeriodicalId\":17542,\"journal\":{\"name\":\"Journal of thoracic disease\",\"volume\":\"17 8\",\"pages\":\"5654-5662\"},\"PeriodicalIF\":1.9000,\"publicationDate\":\"2025-08-31\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12433019/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of thoracic disease\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.21037/jtd-2025-433\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/8/28 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"RESPIRATORY SYSTEM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of thoracic disease","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.21037/jtd-2025-433","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/8/28 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 0

摘要

背景:肺部症状在长冠状病毒病(COVID)中很常见,但胸部计算机断层扫描(CT)对这些患者的诊断价值尚不清楚,特别是在体格检查和肺功能检查正常的情况下。本研究旨在探讨胸部CT是否会影响肺部医师对疑似肺部长冠肺炎患者采取诊断检查措施、最终诊断、诊断信心以及后续处理的决策。方法:2020年4月至2021年8月期间,所有患者在一家二级保健医院专门的肺部疾病长门诊就诊。纳入标准为年龄≥18岁,根据国家卫生与保健卓越研究所(NICE)标准怀疑肺部源性长冠状病毒综合征,以及在体检期间获得胸部CT。三名肺炎专家分两轮评估患者的记录(第一轮不知道CT结果,第2轮知道CT结果)。在两次运行中查询相同的参数:肺长冠状病毒的诊断,诊断的置信度(从0到3),需要:支气管肺泡灌洗(BAL),经支气管活检(TBB),低温活检,视频辅助胸腔镜(VATS),肺活量测定,通气/灌注成像,随访预约,康复。结果:纳入41例患者,其中男性24例,年龄21 ~ 72岁,平均55岁。第一、第二轮诊断为肺长冠肺炎的患者分别为10例(24%)和11例(27%)(P=0.69)。诊断置信度分别为1.9和2.6 (p)。结论:胸部CT对疑似肺部长冠肺炎患者的诊断决策没有影响。然而,胸部CT提高了对诊断的信心。尽管如此,根据我们的结果,当肺功能检查和听诊正常时,胸部CT不需要常规地包括在长期COVID的检查中。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Chest computed tomography findings do not influence the decision of pneumologists regarding the diagnosis and management of pulmonary long coronavirus disease: a single center retrospective study.

Chest computed tomography findings do not influence the decision of pneumologists regarding the diagnosis and management of pulmonary long coronavirus disease: a single center retrospective study.

Background: Pulmonary symptoms are common in long coronavirus disease (COVID), yet the diagnostic value of chest computed tomography (CT) in these patients remains unclear, particularly when physical examination and pulmonary function tests are normal. This study investigates whether chest CT influences the decision of pneumologists regarding the measures taken for diagnostic work-up, the final diagnosis, the confidence in the diagnosis, and the downstream management of patients suspected to suffer from pulmonary long COVID.

Methods: All patients presented in a dedicated long COVID outpatient clinic of a secondary care hospital that specializes in lung diseases between April 2020 and August 2021. Inclusion criteria were age ≥18 years, suspicion for long COVID syndrome of pulmonary origin according to the National Institute for Health and Care Excellence (NICE) criteria and availability of a chest CT acquired during work-up. Three pneumologists evaluated the patient's records in two rounds (round 1 without and round 2 with knowledge of CT results). Identical parameters were queried in the two runs: diagnosis of pulmonary long COVID, confidence of the diagnosis on a scale from 0 to 3, need for: bronchoalveolar lavage (BAL), transbronchial biopsy (TBB), cryobiopsy, video-assisted thoracoscopy (VATS), ergospirometry, ventilation/perfusion scintigraphy, follow-up appointment, rehabilitation.

Results: Forty-one patients were included (24 male; age 21 to 72 years, mean 55 years). In the first and second round diagnosis of pulmonary long COVID was made in an average of 10 (24%) and 11 (27%) patients (P=0.69). Confidence of diagnosis was 1.9 and 2.6 (P<0.001). No statistical difference was found regarding the frequency of diagnostic measures and downstream management.

Conclusions: Chest CT did not influence the diagnostic decision of pneumologists for patients suspected to suffer from pulmonary long COVID. However, the confidence in the diagnosis was improved by chest CT. Still, based on our results chest CT does not routinely have to be included in the work-up of long COVID, when pulmonary function tests and auscultation are normal.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Journal of thoracic disease
Journal of thoracic disease RESPIRATORY SYSTEM-
CiteScore
4.60
自引率
4.00%
发文量
254
期刊介绍: The Journal of Thoracic Disease (JTD, J Thorac Dis, pISSN: 2072-1439; eISSN: 2077-6624) was founded in Dec 2009, and indexed in PubMed in Dec 2011 and Science Citation Index SCI in Feb 2013. It is published quarterly (Dec 2009- Dec 2011), bimonthly (Jan 2012 - Dec 2013), monthly (Jan. 2014-) and openly distributed worldwide. JTD received its impact factor of 2.365 for the year 2016. JTD publishes manuscripts that describe new findings and provide current, practical information on the diagnosis and treatment of conditions related to thoracic disease. All the submission and reviewing are conducted electronically so that rapid review is assured.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信